Back to Search
Start Over
Efficacy comparison of tisagenlecleucel vs usual care in patients with relapsed or refractory follicular lymphoma
- Source :
- Blood Advances; November 2022, Vol. 6 Issue: 22 p5835-5843, 9p
- Publication Year :
- 2022
-
Abstract
- •Our study contextualizes the single-arm ELARA trial by providing historical control data from clinically similar patients on usual care.•Tisagenlecleucel was shown to have superior efficacy than usual care in patients with multiply relapsed or refractory follicular lymphoma.
Details
- Language :
- English
- ISSN :
- 24739529 and 24739537
- Volume :
- 6
- Issue :
- 22
- Database :
- Supplemental Index
- Journal :
- Blood Advances
- Publication Type :
- Periodical
- Accession number :
- ejs61827661
- Full Text :
- https://doi.org/10.1182/bloodadvances.2022008150